Publicaciones en las que colabora con MIGUEL FERNÁNDEZ ARQUERO (15)

2016

  1. Monitoring the John Cunningham virus throughout natalizumab treatment in multiple sclerosis patients

    European Journal of Neurology, Vol. 23, Núm. 1, pp. 182-189

2014

  1. HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-ß therapy in multiple sclerosis

    Journal of Medical Genetics, Vol. 51, Núm. 6, pp. 395-400

2011

  1. Validation of IRF5 as multiple sclerosis risk gene: Putative role in interferon beta therapy and human herpes virus-6 infection

    Genes and Immunity, Vol. 12, Núm. 1, pp. 40-45

2010

  1. Chromosomal region 16p13: Further evidence of increased predisposition to immune diseases

    Annals of the Rheumatic Diseases, Vol. 69, Núm. 1, pp. 309-311

  2. Polymorphisms in the IL2, IL2RA and IL2RB genes in multiple sclerosis risk

    European Journal of Human Genetics, Vol. 18, Núm. 7, pp. 794-799

2009

  1. Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility

    Genes and Immunity, Vol. 10, Núm. 7, pp. 631-635

2008

  1. Association of the STAT4 gene with increased susceptibility for some immune-mediated diseases

    Arthritis and Rheumatism, Vol. 58, Núm. 9, pp. 2598-2602

  2. IFIH1-GCA-KCNH7 locus: Influence on multiple sclerosis risk

    European Journal of Human Genetics, Vol. 16, Núm. 7, pp. 861-864

2007

  1. FcRL3 and multiple sclerosis pathogenesis: Role in autoimmunity?

    Journal of Neuroimmunology, Vol. 189, Núm. 1-2, pp. 132-136

2005

  1. Early B-cell factor gene association with multiple sclerosis in the Spanish population

    BMC Neurology, Vol. 5

2004

  1. TNF-376A marks susceptibility to MS in the Spanish population A replication study

    Neurology, Vol. 62, Núm. 5, pp. 809-810

2002

  1. Interleukin-10 polymorphisms in Spanish multiple sclerosis patients

    Journal of Neuroimmunology, Vol. 131, Núm. 1-2, pp. 168-172

1999

  1. Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis

    Neurology, Vol. 53, Núm. 6, pp. 1361-1363

  2. Susceptibility to multiple sclerosis mediated by HLA-DRB1 is influenced by a second gene telomeric of the TNF cluster

    Human Immunology, Vol. 60, Núm. 12, pp. 1266-1273

1997

  1. Combined effect of HLA-DRB1* 1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis

    Journal of Neuroimmunology, Vol. 80, Núm. 1-2, pp. 172-178